One hundred and sixteen insulin treated diabetic patients were evaluated for the relationship between the presence of microalbuminuria and several lipid, glyco-metabolic, coagulation and fibrinolysis factors. A significant correlation existed only between microalbuminuria and HbA lc (r = 0.23, p = 0.008) and D-dimer (r = 0.28, p = 0.002). After the subdivision of the patients in a group without (n = 85) and a group with microalbuminuria (n = 31) significant differences were found between these two groups for the HDL-cholesterol content (p < 0.05), the HbAi c level (p < 0.01) and for the D-dimer concentration (p < 0.01).
Introduction
(2). This stage can be defined äs the period in which The occurrence of nücroalbuminuria (1) is accepted the mean urinary albumin excretion rate is signifias an early indicator of microangiopathy in diabetes cantly higher g/min) than that in reference mellitus i. e: diabetic nephropathy. The onset of the subjects (3) . The clinical syndrome of diabetic neclinical Symptoms of diabetic nephropathy may be phropathy is characterised by persistent proteinuria preceded by a silent period of variable duration düring (4) , accompanied by increased morbidity and mortalwhich diabetic patients show only microalbuminuria ity in diabetic patients (5 -11) . Düring the stage of clinical proteinuria and progressive renal failure, there are changes in the plasma lipoprotein concentration (12) (13) (14) which are thought to contribute to the increased cardiovascular risk. Recently, in a case-control study (15) , the concentrations of lipoproteins, apolipoproteins, fibrinogen and factor VII were compared in insulin-dependent diabetic patients with (n = 20) and without (n = 20) microalbuminuria under similar glyco-metabolic control
In this study we have investigated the correlation between the microalbuminuria and the following parameters: several lipid fractions (cholesterol, HDLcholesterol, LDL-cholesterol, triacylglycerol); parameters for glyco-metabolic control (HbA ic and fructosamine) (16, 17) ; the routine clotting test fibrinogen; sensitive indicators for clotting activation like fibrin monomers and the thrombin-antithrombin-III complex (18) ; and the fibrinolysis factors, plasminogen activator inhibitor (19, 20) and D-Dimer, the latter being a sensitive indicator of the onset of reactive fibrinolysis (21) . The aim of the study was to investigate the possibility that biochemical parameters other than urinary microalbumin excretion rates possess predictive value for the occurrence of diabetic angiopathy.
Materials and Methods

Methods
The serum samples were analysed with a Cobas Bio centrifugal fast analyser and commercial test kits according to the manufacturer's instructions were used. We collected venous blood samples between 8.30 and 9.00 a.rn. and prepared citrated plasma by centrifugation of niiie volumes of freshly drawn blood with one volume of trisodium citrate (0.11 mol/1) for 30 min at 25 °C (1600 g). The plasma was used immediately or stored at --70 °C in plastic tubes and thawed with tap water for 5 min before use. For the glyco-metabolic determinations washed red cells were haemolysed and the haemolysate äs such was used for the Chromatographie Separation of HbAi c . Urine samples for urinary albumin determination were obtained from a moraing portion after collecting overnight, and the time of collection was recorded.
Statistics
Correlations between the different parameters and urinary microalbumin were investigated by the Spearman rank test. The significance of the differences was assesseÖ by the Mann-Whitney^Wilcoxon test. The sensitivity and specificity of HbAi c and Dfdimer were calculated according to the presence or absence of microalbuminuria äs the decision Standard (cut-off level 20 g/min). Receiver Operating Characteristic (ROC) curves for assessing the power of the teste were constructed äs described earlier (22) .
; r Tab. 1. General characteristics of the patients according to the albumin excretion rate. Values are means (SD). The number of the patients with retinopathy, and neuropathy are given s percentages. 
Results
The Spearman rank collection between urinary microalbumin concentrations and several biochemical parameters is given in table 2. Significant correlations with microalbuminuria were found only for HbAi c and D-dimer, with r values of 0.232 (p = 0.008 and 0.278 (p = 0.002) respectively. In table 3 the diabetic patient groups without (< 20 μg/min) and with (> 20 μg/min) albuminuria are compared with a healthy volunteers group without albuminuria. No significant differences for either diabetic group were found for cholesterol, cholesterol/HDL-cholesterol ratio, LDLcholesterol, thrombin-antithrombin III complex and plasminogen activator inhibitor. Additionally, fibrinogen levels were not significantly altered in the group with a high lb miri excretion rate. The other parameters showed highly significant differences betweeri the two patient groups and the volunteer group. Mutual comparison of the two patient groups s given in table 4 showed a significant decrease for HDL- To assess the predictive power of the HbA JC in relation to the microalbuminuria, a ROC-curve ( fig. 1 ) was calculated at different cut-off levels of the test against microalbuminuria s the reference parameter at the cut-off decision level 20 μg/min. For the HbA lc r nge from 6% to 12% the sensitivity ranged from 38% to 100%, the specificity from 85% to 65%. 
<0.01
Discussion
The general characteristics of the studied diabetic population, äs shown in table l, contain data that need some clarification. The reported mean values for blood pressure and urinary albumin excretion in patients with a mean duration of diabetes mellitus of 14 years indicate, äs mentioned in the patients section, that patients with hypertension and "macroalbuminuria" were excluded from the study. Possibly therefore we found no differences in mean systolic and diastolic blood pressure between the diabetic patients with and without microalbuminuria. The correlation between microalbuminuria and several biochemical Parameters was shown to be significant only for HbA lc and D-dimer (tab. 2). These results suggest an increased prevalence of microalbuminuria associated with poorer glycaemic control and augmented reactive fibrinolysis (probably after preceding coagulation activation). Recently, we described an increase of coagulation activation with a decreased efficiency of glyco-metabolic control (23), äs well äs a relative decrease of the elevated reactive fibrinolysis with increasing HbAi c (24) in a large population of insulindependent diabetic patients. Thus, the D-dimer level might be an indirect indicator of long term sequelae of diabetes mellitus such äs microalbuminuria.
Comparison of the insulin-dependent diabetics with or without microalbuminuria with a group of healthy individuals showed significant alterations in some lipid parameters (HDL-cholesterol, triacylglycerol) and in some coagulation and fibrinolysis parameters (fibrin monomer, D-dimer). Several factors might be responsible for the differences between the three groups, but most probable is the influence of the glycaemic control. In young insulin-dependent diabetics, the glyco-metabolic control state has been shown to influence the lipoprotein serüm concentrations (25) (26) (27) äs well äs the prevalence of microalbuminuriä, whereäs changes in the lipid fractions have been described in diabetics with microalbuminuria and with pöor glycaemic eontrol (13) .
Recently triacylglycerol has been reported to enhance the activation of coagulation factor VII (28), leading to thrombin formatipn and hence to fibrin monomer formation and reactive fibrinolysis (D-dimers). Becatise serum triacylglycerol correlates with plasminogen activator inhibitor, fibrinolysis might be impaired when triacylglycerol is elevated (29) . Möreover increased serum triacylglycerol äs well äs elevated plasminogen activator inhibitor levels have been observed to be strongly related to an enhanced risk of ischaemic heart disease (30) (31) (32) (33) (34) . The two diabetic groups of the present study differ from the reference group with respect to those parameters known to be correlated with an enhanced risk of cardiovascular disease. In the mutual comparison of the two diabetic patient groups with and without microalbuminuria (tab. 4) the HDL-cholesterol concentration, a known risk factor for cardiovascular disease, was significantly decreased in the microalbuminuria group. Moreover, there appeared to be an enhanced clotting activation (fibrin monomers) with reactive fibrinolysis (D-dimer) in both diabetic groups, whereas HbA lc was higher in the microalbuminuria group, indicating poorer glycaemic control. In view of the relative decrease of the fibrinolysis level with increasing HbA lc which we reported earlier (24) , there might, however, be insufficient reactive fibrinolysis for the extent of the signalized coagulation activation. For the testing of the power of HbAi c äs a predictive parameter for microalbuminuria we constructed a ROC curve for HbA lc at different cut-off levels. The ROC curve showed 100% sensitivity for the prediction of microalbuminuria (> 20 g/min) at a cut-off level of 12% HbA lc . Moreover, i t should be noted that between 11% and 12% HbA lc there is a jump in the prediction sensitivity from 66.7 to 100%; which might be another indication for setting the goal of glycaemic control at least below the value of 11 % HbAi c . Nevertheless it seems worthwile from the course of the ROC curve to pursue a normoglycaemia, because in that ränge a decrease of the sensitivity is achievable from 66.7% (at a HbA lc level of 11%) to 37.8% (at a HbA lc level of 6%). This finding agrees with the results Klein et al. (35) , who demonstrated a strong and consistent relation between hyperglycaemia and the incidence and progression of retinopathy, and who einphasized the importance of normoglycaemia in diabetics.
Conclusion
The results of this study show that in insulin-treated diabetics with microalbuminuria glycaemic control is significantly poorer than in the patients without microalbuminuria. Several abnormalities are significantly more pronounced in the microalbuminuria than in the non-microalbuminuria group; the lipid fractions contain lower HDL-cholesterol and higher triacylglycerol, which are prerequisites for the develppment of atherosclerosis. Of the coagulation and fibrinolysis factors, the elevation of the fibrin monomer and the D-dimer values should be noted, because they indicate an activation of coagulation, possibly with relatively insufficient reactive fibrinolysis in poor glycaemic control, thereby possibly also constituting risk factors for coronary heart disease. We did not, however, observe a direct correlation between coagulation and fibrinolysis and the existence of microalbuminuria in the diabetic patient groups.
